Arovella Therapeutics Advances iNKT Cell Therapy Platform
PremiumCompany AnnouncementsArovella Therapeutics Advances iNKT Cell Therapy Platform
28d ago
Arovella Therapeutics Enhances Expertise for Upcoming Trials
Premium
Company Announcements
Arovella Therapeutics Enhances Expertise for Upcoming Trials
30d ago
Arovella Therapeutics Sets Date for 2024 AGM
Premium
Company Announcements
Arovella Therapeutics Sets Date for 2024 AGM
1M ago
Arovella Therapeutics Webinar on iNKT Cell Therapy
PremiumCompany AnnouncementsArovella Therapeutics Webinar on iNKT Cell Therapy
2M ago
Arovella Therapeutics Updates on iNKT Cell Therapy Progress
Premium
Company Announcements
Arovella Therapeutics Updates on iNKT Cell Therapy Progress
2M ago
Arovella Therapeutics Emphasizes ESG Commitment
Premium
Company Announcements
Arovella Therapeutics Emphasizes ESG Commitment
2M ago
Arovella’s ALA-101 Gains FDA Nod Towards Trials
PremiumCompany AnnouncementsArovella’s ALA-101 Gains FDA Nod Towards Trials
3M ago
Arovella Therapeutics Advances Cancer Cell Therapy
Premium
Company Announcements
Arovella Therapeutics Advances Cancer Cell Therapy
4M ago
Arovella Therapeutics Expands Share Capital
Premium
Company Announcements
Arovella Therapeutics Expands Share Capital
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100